Topics

Chan Soon-Shiong Institute for Medicine Company Profile

07:35 EDT 18th September 2019 | BioPortfolio


News Articles [1477 Associated News Articles listed on BioPortfolio]

STAT Plus: A small drug maker accuses Soon-Shiong of masterminding a ‘catch-and-kill’ scheme

Sorrento alleges Soon-Shiong conspired to thwart its efforts to commercialize Cynviloq, which would have rivaled Abraxane, a cancer drug Soon-Shiong developed.

Sorrento Takes Aim at Billionaire Patrick Soon-Shiong, Files Lawsuit Over 2015 Cynviloq Deal

The lawsuit alleges that Soon-Shiong acquired the promising cancer treatment in order to prevent it from coming to market and challenging revenues from Celgene's Abraxane, a drug Soon-Shiong developed...

Diana Chan

bmj;364/feb21_1/l771/FAF1faDiana Chan (Vugler) was born and brought up in Bangor, north Wales. She was the youngest of seven siblings. Diana studied medicine at the University of Sheffield and...

Patrick Soon-Shiong Sued Over 'Catch and Kill' of Cancer Drug

Sorrento Therapeutics alleges that controversial billionaire Soon-Shiong prevented a bioequivalent of Abraxane from coming to the US market. Medscape Medical News

Sorrento Therapeutics seek $1 billion from billionaire biotech investor Patrick Soon-Shiong

Sorrento Therapeutics is seeking $1 billion in damages from billionaire biotech investor Patrick Soon-Shiong, owner of US newspaper the LA Times.   The legal action comes after Sorrento accused S...

Patrick Soon-Shiong: The biotech billionaire with a 19% stake in Directa Plus

Soon-Shiong’s investment in Directa Plus means he is the third overseas billionaire in as many months to take a sizeable stake in an AIM company

Billionaire Los Angeles Times Owner Patrick Soon-Shiong Accused Of ‘Catch-And-Kill’ Scheme—With A Cancer Drug

Sorrento Therapeutics alleges in a complaint that billionaire Soon-Shiong kept a cancer drug from making it to market to eliminate a competitor to a drug he invented.

STAT Plus: Sorrento alleges Soon-Shiong conspired to thwart its efforts to commercialize Cynviloq, which would have rivaled Abraxane, a cancer drug Soon-Shiong developed. https://buff.ly/2Uf7eoH 

STAT Plus: Sorrento alleges Soon-Shiong conspired to thwart its efforts to commercialize Cynviloq, which would have rivaled Abraxane, a cancer drug Soon-Shiong developed. https://buff.ly/2Uf7eoH ...

Drugs and Medications [14 Associated Drugs and Medications listed on BioPortfolio]

Fludeoxyglucose f18 [the methodist hospital research institute]

Fludeoxyglucose F18 Injection USP - NO CHANGE

Epinephrine hypospray(r) [langford research institute]

Epinephrine HypoSpray

Clinpro 5000 [3m espe dental products]

These highlights do not include all the information needed to use 3M ESPE Clinpro 5000 Anti-Cavity Toothpaste safely and effectively. See full prescribing information for Clinpro 5000 Anti-Cavity Toot...

Oral-b neutra-foam mint [oral-b laboratories]

Package. Label Principal Display Panel

Azelaic acid gel [sandoz inc]

These highlights do not include all the information needed to use AZELAIC ACID GEL safely and effectively. See full prescribing information for AZELAIC ACID GEL.AZELAIC ACID GEL, 15% for topical UseIn...

PubMed Articles [1180 Associated PubMed Articles listed on BioPortfolio]

Chemoselective Chan-Lam Coupling Reactions between Benzimidazoline-2-Thiones and Arylboronic Acids.

An efficient Chan-Lam-type methodology for the selective synthesis of S-arylbenzimidazoles and N,S-diarylbenzimidazoles was developed. The selectivity was controlled by varying the amount of the catal...

Lower daily carbohydrate consumption than recommended by the Institute of Medicine is common among women with type 2 diabetes in early pregnancy in Denmark.

To secure adequate carbohydrate supply in pregnancy, the Institute of Medicine (IOM) recommends a minimum amount of carbohydrates of 175 g daily. Currently a low carbohydrate diet is a popular health ...

Isolated Bilateral Rocker Bottom Feet Associated With 2q13 Microdeletion.

Just Because There is a Button Doesn't Mean it is Appropriate to Use or That it will Give Accurate Information.

Group Acupuncture Model in a Cancer Institute: Improved Access and Affordability.

Cancer patients may experience significant symptom mitigation from acupuncture. However, this service may not be easily accessible or affordable at all cancer institutions. The development of a group ...

Clinical Trials [2406 Associated Clinical Trials listed on BioPortfolio]

Measuring Herpes Zoster and PHN Associated Burden of Illness and Health Care Utilization Costs in Thailand

Total 7 institutions will be recruited i.e. Clinical Infectious Disease Research Unit Department of Clinical Tropical Medicine, Faculty of Tropical Medicine Mahidol University,Bamrasnara...

Consultation Reasons in Family Medicine

The Tunisian society of family medicine STMF proposes to coordinate a national, observational, transversal and multicenter survey, at the consultations of general medicine / family medicin...

A Registry Study of 100 Thousand Cases of Pediatric Patients on Reduning Injection(a Chinese Medicine Injection)Used in Hospitals in China

This study was advocated by Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences in February 2018. The purpose of this study is to make a monitoring...

Rady Children's Institute Genomic Biorepository

Rady Children's Institute for Genomic Medicine (RCI) will collect biological samples (such as blood), derived genomic sequences (from DNA and RNA), and clinical features in a Biorepository...

Pilot Study on Traditional Chinese Medicine and Food Allergy

Recently, there has been an increasing interest in using traditional Chinese medicine for food allergy. The Harvard group has successfully demonstrated the Food Allergy Herbal Formula - F...

Companies [2279 Associated Companies listed on BioPortfolio]

Chan Soon-Shiong Institute of Molecular Medicine

Chan Soon-Shiong Institute of Molecular Medicine (CSSIOMM) is a division of the Chan Soon-Shiong NantHealth Foundation, a 501(c)(3) non-profit medical research organization focuse...

Chan Soon-Shiong Institute for Molecular Medicine

Chan Soon-Shiong Institute of Molecular Medicine (CSSIOMM) is a division of Chan Soon-Shiong NantHealth Foundation, a 501(c)(3) non-profit medical research organization focused on...

Chan Soon-Shiong Institute for Medicine

Chan Soon-Shiong Institute for Advanced Health

Chan Soon-Shiong Institute of Molecular Medicine at Windber

CSS Institute is a private, non-profit biomedical research institute established in 2000, as the Windber Research Institute, with a mission to improve patients’ care through ...

More Information about "Chan Soon-Shiong Institute for Medicine" on BioPortfolio

We have published hundreds of Chan Soon-Shiong Institute for Medicine news stories on BioPortfolio along with dozens of Chan Soon-Shiong Institute for Medicine Clinical Trials and PubMed Articles about Chan Soon-Shiong Institute for Medicine for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Chan Soon-Shiong Institute for Medicine Companies in our database. You can also find out about relevant Chan Soon-Shiong Institute for Medicine Drugs and Medications on this site too.

Quick Search

Corporate Database Quicklinks



Searches Linking to this Company Record